Effect of Sodium Glucose Cotransporter Inhibitors on Non Diabetic Fatty Liver Disease Patients
Condition(s):Fatty Liver DiseaseLast Updated:January 23, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Fatty Liver DiseaseLast Updated:January 23, 2023Not yet recruiting
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:June 18, 2023Not yet recruiting
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:November 14, 2022Recruiting
Condition(s):Fatty Liver Disease; Fatty InfiltrationLast Updated:July 20, 2020Completed
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:February 21, 2023Recruiting
Condition(s):Esophageal Varices; Non-alcoholic Fatty Liver; Compensated CirrhosisLast Updated:January 11, 2024Completed
Condition(s):Liver SteatosesLast Updated:August 15, 2023Recruiting
Condition(s):Nonalcoholic Fatty Liver Disease; Type 2 Diabetes MellitusLast Updated:October 5, 2023Recruiting
Condition(s):Heart Failure With Preserved Ejection Fraction; Non Alcoholic Fatty LiverLast Updated:April 21, 2023Not yet recruiting
Condition(s):Nonalcoholic Fatty Liver DiseaseLast Updated:August 10, 2022Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.